Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

164 recalls, newest first

Class II · Moderate risk

Yeast Arrest

cGMP violations

Terminated cGMP deviation Wisconsin Pharmacal Company, LLC NDC 68093-0730-1 D-0781-2020
Class II · Moderate risk

Budesonide 0.4mg

Lack of Processing Controls

Terminated cGMP deviation Integrated Health Concepts Inc. dba Conversio Health D-0508-2020
Class II · Moderate risk

R2103

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0506-2020
Class II · Moderate risk

StellaLife VEGA Oral Gel Rinse

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0505-2020
Class II · Moderate risk

Pareira (Brava)

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0504-2020
Class II · Moderate risk

Silicea 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0503-2020
Class II · Moderate risk

Natrum Sulphuricum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0502-2020
Class II · Moderate risk

Natrum Phosphoricum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0501-2020
Class II · Moderate risk

Natrum Muriaticum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0500-2020
Class II · Moderate risk

Magnesia Phosphorica 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0499-2020
Class II · Moderate risk

Kali Sulphuricum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0498-2020
Class II · Moderate risk

Kali Phosphoricum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0497-2020
Class II · Moderate risk

Kali Muriaticum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0496-2020
Class II · Moderate risk

Ferrum Phosphoricum 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0495-2020
Class II · Moderate risk

Cell Salts Combination 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0494-2020
Class II · Moderate risk

Calcarea Sulphurica 6X Tablets

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-0493-2020

Recalls by year